PharmaNet/i3, inVentiv Health’s clinical segment and a provider of clinical development services, has appointed Dr. Susan C. Stansfield as executive vice president of clinical operations for phase II-IV development in Europe, Middle East and Africa (EMEA), Asia-Pacific and Latin America. 

Stansfield has successfully held senior leadership positions at other global clinical research organizations. She has a proven record of significantly enhancing clinical operations and customer satisfaction. Stansfield received her BSc in physiology and biochemistry from Nottingham University (U.K.) and her PhD in neuropharmacology from Reading University (U.K.).